Ray Therapeutics and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing Partnership Read more
European Medicines Agency (EMA) accepts marketing authorisation application for daprodustat Read more
Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID Read more
KEYTRUDA (pembrolizumab) Plus LENVIMA (lenvatinib) Approved in Japan for Radically Unresectable or Metastatic Renal Cell Carcinoma Read more
Virios Therapeutics Announces Research Collaboration Exploring the Potential of Combination Antiviral Therapy for Treating Long COVID Read more